Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Melanoma 14Glioblastoma 10Pancreatic Neoplasms 9Breast Neoplasms 9Neoplasms 8Glioma 8Prostatic Neoplasms 5Colonic Neoplasms 5Triple Negative Breast Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Ovarian Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Carcinoma 4Astrocytoma 4Oligodendroglioma 3Fallopian Tube Neoplasms 3Colorectal Neoplasms 3Central Nervous System Neoplasms 3Carcinoma, Merkel Cell 3Carcinoma, Hepatocellular 3Brain Neoplasms 3Urinary Bladder Neoplasms 2Stomach Neoplasms 2Small Cell Lung Carcinoma 2Sarcoma 2Osteosarcoma 2Neoplasms, Plasma Cell 2Neoplasm Metastasis 2Myelodysplastic Syndromes 2Lymphoma, T-Cell, Cutaneous 2

Interventions

Tamoxifen 16Radiotherapy 9Anastrozole 8Letrozole 7Chemotherapy, Adjuvant 7Specimen Handling 6Radiation 5Neoadjuvant Therapy 5Mastectomy, Segmental 5Biopsy 5Sentinel Lymph Node Biopsy 4Psychiatric Rehabilitation 4Mass Spectrometry 4Immunohistochemistry 4Gene Expression Profiling 4Early Intervention, Educational 4Counseling 4exemestane 3afimoxifene 3Surveys and Questionnaires 3Surgical Procedures, Operative 3Methods 3Mastectomy 3Magnetic Resonance Spectroscopy 3Fatty Acids, Omega-3 3Chromatography, High Pressure Liquid 3pasireotide 2Trastuzumab 2Standard of Care 2Soybean Proteins 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Carcinoma, Intraductal, Noninfiltrating × poly ICLC × Clear all
NCT06218303 2026-03-12

Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ

University of Pittsburgh

Phase 1 Recruiting
50 enrolled
Breast

Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡